Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
102,089,423
-
Total 13F shares
-
86,186,499
-
Share change
-
-7,801,049
-
Total reported value
-
$560,206,343
-
Put/Call ratio
-
67%
-
Price per share
-
$6.50
-
Number of holders
-
173
-
Value change
-
-$67,566,969
-
Number of buys
-
97
-
Number of sells
-
88
Institutional Holders of Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN) as of Q2 2025
As of 30 Jun 2025,
Day One Biopharmaceuticals, Inc. - COMMON STOCK (DAWN) was held by
173 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
86,186,499 shares.
The largest 10 holders included
FMR LLC, BlackRock, Inc., Atlas Venture Life Science Advisors, LLC, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, DEERFIELD MANAGEMENT COMPANY, L.P., Pictet Asset Management Holding SA, Alyeska Investment Group, L.P., Vestal Point Capital, LP, and STATE STREET CORP.
This page lists
173
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.